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379 Abstract
80 This study presents the development of a worldwide inter-laboratory testing scheme for the analysis 
81 of seven illicit drug residues in different matrices (standard solutions, tap- and wastewater). By 
82 repeating this exercise for six years with participation of 37 laboratories from 25 countries, the 
83 testing scheme was substantially improved based on experiences gained across the years (e.g. matrix 
84 type, sample conditions, spiking levels). From the exercises, (pre-)analytical issues (e.g. pH 
85 adjustment, filtration) were revealed for some analytes which resulted in formulation of best-
86 practice protocols, both for inter-laboratory setup and analytical procedures. The results illustrate 
87 the effectiveness of the inter-laboratory testing scheme in assessing laboratory performance in the 
88 framework of illicit drug analysis in wastewater. The exercise proved that measurements of 
89 laboratories were of high quality (> 80% satisfactory results for 6 out of 7 analytes) and that 
90 analytical follow-up is important to assist laboratories in improving robustness of wastewater-based 
91 epidemiology results. 
92
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495 1. Introduction
96 The measurement of the human excretion products of illicit drugs in influent wastewater has been 
97 recognized as an alternative and complementary approach for estimating the consumption of illicit 
98 drugs within communities, i.e. the catchment of wastewater treatment plants (WWTPs) [1-3]. The 
99 principle behind wastewater-based epidemiology (WBE) derives from the fact that parent 
100 compounds and/or their human metabolites (i.e., drug residues) are excreted in urine and faeces 
101 following illicit drug use and end up in urban sewer systems [3]. The ability of WBE to provide useful 
102 and timely information on temporal (daily, weekly, monthly, and annually) and spatial (within- and 
103 between-countries) variations in illicit drug consumption has been demonstrated [4-15]. The 
104 European Monitoring Centre for Drug and Drug Addiction (EMCDDA) has recently acknowledged the 
105 added value of WBE to socio-epidemiological methods, such as population surveys, seizure data and 
106 crime statistics, in generating useful and relevant data on population drug use [3].
107
108 With the aim to improve and optimize WBE, a Europe-wide collaboration was initiated in 2010. Seven 
109 European institutions – University of Antwerp (BE), Eawag (CH), University Jaume I (ES), Mario Negri 
110 Institute (IT), KWR Watercycle Research Institute (NL), Norwegian Institute for Water Research NIVA 
111 (NO), and University of Bath (UK) - established the research group SCORE (Sewage analysis CORe 
112 group Europe) [16]. The ultimate goals of SCORE are (a) to collaborate in the field of WBE to provide 
113 reproducible data; (b) to improve and harmonize the analytical procedures used in different 
114 laboratories to analyze drug residues in wastewater samples; and (c) to perform international studies 
115 comparing illicit drug consumption in communities across the world. To this end, SCORE has 
116 coordinated monitoring studies and exercises to assure the quality of reported data based on agreed 
117 best-practices tackling sampling, storage and analysis. Important results from this collaboration are 
118 multi-city studies demonstrating the usefulness of WBE on an international level to obtain the most 
119 recent data on illicit drug consumption [17-18]. 
120
121 In order to further optimize and fine-tune WBE, it is imperative to gain knowledge on the sources of 
122 uncertainties that are associated with the approach. In 2013, SCORE performed a thorough 
123 evaluation on the uncertainties of WBE using the best-practice protocols and data that were 
124 available from the comparative Europe-wide WBE research [19]. One of the cornerstones of WBE is 
125 to accurately quantify concentrations of drug residues in wastewater samples by means of reliable 
126 analytical procedures [20]. This requires fully validated analytical procedures before routine analysis 
127 can be initiated and participation in external quality control schemes is, where possible, highly 
128 recommended. External quality control through inter-laboratory exercises are based on the 
5129 distribution of the same test samples (in our case prepared by NIVA) to all participants. The latter 
130 analyse all test samples without any knowledge of the concentrations of target analytes and return 
131 their results to the coordinator of the exercise (in our case Eawag, who does not analyse test samples 
132 and does not know the nominal spike value until final compilation of results). The coordinator 
133 converts the submitted results into objective scores that reflect the performance of individual 
134 laboratories and the group. These scores can alert participants of unexpected problems and can 
135 result in actions to be taken [21]. 
136
137 SCORE initiated inter-laboratory exercises in 2011 in order to develop a quality control scheme for 
138 laboratories that analyze illicit drug residues in wastewater for WBE purposes. Since its debut, the 
139 testing scheme has been carried out annually with increasing participation of different laboratories, 
140 also extending the network outside Europe.  The objectives of the presented interlaboratory exercise 
141 are (a) to illustrate the results of the six-year inter-laboratory testing scheme; (b) to evaluate 
142 advancements achieved over these years and to identify issues still to be resolved; (c) to formulate 
143 recommendations for future inter-laboratory exercises and (d) to propose a robust quality control 
144 system to improve the analytical performance of laboratories analyzing illicit drugs in wastewater. 
145
146 2. Setup of the inter-laboratory exercises
147 2.1. Target analytes
148 A total of seven illicit drug residues were targeted in the inter-laboratory testing scheme. These 
149 included cocaine (COC), benzoylecgonine (BE, cocaine metabolite), 3,4-methylenedioxy-
150 methamphetamine (MDMA), amphetamine (AMP), methamphetamine (METH), 11-nor-9-carboxy-
151 tetrahydrocannabinol (THC-COOH, THC metabolite), and 6-monoacetylmorphine (6-MAM, heroin 
152 metabolite). These analytes are widely regarded as the main urinary biomarkers of the worldwide 
153 most consumed illicit drugs (COC, MDMA, AMP, METH, cannabis and heroin) and are the focus of 
154 most bioanalytical and WBE initiatives around the world [22]. Certified spiking solutions of each of 
155 the target analytes were supplied by Cerilliant Corporation (Round Rock, Texas, USA). All spiking 
156 solutions were supplied in sealed glass ampoules at 1 mg/mL in methanol.
157
158 2.2. Design of the exercises 
159 The basis of the inter-laboratory testing scheme was to compare the performance of the analytical 
160 procedures employed by participating laboratories. Two separate modules were included to evaluate 
161 in each laboratory (a) the use of correct analytical reference standards and the performance of the 
6162 instrumental analysis (Module 1), and (b) the performance of entire analytical procedures applied to 
163 the analysis of wastewater, including sample preparation (Module 2). 
164
165 For Module 1, a methanol solution containing the seven target analytes was used. For Module 2, 
166 samples of tap water and wastewater spiked with the seven analytes were employed. Participants 
167 were asked to use their own in-house developed and validated analytical procedures for the analysis 
168 of the samples. Replicate analysis of each sample was requested (n = 5 for Module 1 and n = 3 for 
169 Module 2). Commonly, sample pre-treatment consisted of filtration followed by solid-phase 
170 extraction for Module 2 samples. All laboratories employed liquid chromatography coupled to mass 
171 spectrometry using mass-labelled internal standards to perform detection and quantification of the 
172 analytes. More information on different techniques, including sample preparation procedures, used 
173 for this type of analyses can be found in Castiglioni et al. (2013) and Hernandez et al. (in press) [19-
174 20].
175 Analyte stability in various matrices and conditions is a crucial aspect of any inter-laboratory exercise 
176 as it can substantially affect the outcomes of the analyses, particularly in the absence of certified 
177 reference material in target matrices. Stability of illicit drugs in wastewater has been the subject of 
178 numerous investigations, which were recently reviewed by McCall et al. (2016) [23]. Detailing the 
179 results from all these studies goes beyond the scope of the present paper, however, a brief overview 
180 regarding the analytes targeted in this inter-laboratory exercise is reported here. Both COC and BE 
181 have been shown to be stable in wastewater over multiple weeks when stored refrigerated (4 °C and, 
182 ideally, -20 °C), at low pH and in the dark. Similarly, MDMA, AMP and METH have been shown to be 
183 stable under similar conditions. THC-COOH and 6-MAM, on the other hand, have been shown to be 
184 very sensitive to temperature and, for THC-COOH, low pH. 
185
186 2.3. Preparation of test samples
187 All test samples were prepared by the Norwegian Institute for Water Research (NIVA). Figure 1 and 
188 Table 1 give an overview of the type of test samples included in each year (2011-2016) and the 
189 nominal spiking levels used. The two modules together comprised three matrices (i.e., methanol, tap 
190 water and wastewater) spiked at different concentrations for each of the target analytes. Spiking 
191 concentrations for all matrices changed from year to year to avoid bias and ensure legitimate results. 
192 Certified spiking solutions (1 mg/mL in methanol) were diluted to prepare working solutions at 100 
193 µg/mL or 10 µg/mL in methanol. The working solutions were then used to prepare different test 
194 samples. 
195 The methanol solution (Module 1) containing the analytes was prepared from each of the 100 µg/mL 
196 working solutions. Aliquots (1 mL) of this methanol sample were then transferred to separate glass 
7197 vials and capped. Each vial was accurately weighed and stored at -20 °C ahead of shipment to the 
198 participants. Participants were asked to weigh the samples at arrival and to report deviations from 
199 the weight at preparation.
200 Spiked wastewater and tap water samples (Module 2) were prepared in a 20 L high-density 
201 polyethylene (HDPE) plastic container pre-washed with tap water and methanol. Twenty litres of cold 
202 tap water or fresh wastewater from VEAS WWTP in Oslo (Norway) were poured into the container, 
203 spiked with different volumes of the 10 µg/mL working standard solutions to obtain relevant 
204 concentrations (at ng/L range) and stirred for 2 h to homogenize the mixture. In 2012, one of the 
205 wastewater samples was used as it is; no spiking with target analytes occurred. 
206 Samples from Module 2 were acidified to adjust the pH to 3.5 in 2012 and 2013. This pH adjustment 
207 was agreed upon by the organizers of the exercise as at that time it was assumed that acidification of 
208 samples was the best way to prevent degradation of the analytes [19]. In 2014-2016, no pH 
209 adjustment of the tap water was performed because of the new insight into the negative effect of 
210 low pH on the stability of THC-COOH in wastewater [23-24]. The changes in used matrices and pH 
211 conditions across the years of the inter-laboratory exercise were the result of experiences of 
212 previous years and of advancements made in the field of WBE. 
213 Aliquots of at least 250 mL were placed in HDPE containers and stored at -20 °C before shipping to 
214 the participants. As real wastewater was used, and which likely contained unknown concentrations 
215 of the target analytes, it was not possible to use a genuine “blank” wastewater sample and nominal 
216 values could thus not be reported. Instead, a total value, comprising background concentrations (x) 
217 and the spiked level, was computed (Table 1). 
218
219 2.4. Participants and sample shipping 
220 The inter-laboratory exercises were organized by SCORE and were open to interested participants 
221 from any institution. In order to participate to the exercise, laboratories were required to register 
222 (without any payment) following an invitation sent out by SCORE or through the SCORE website [16]. 
223 Over the period between 2011 and 2016, a total of 37 laboratories from 25 countries participated in 
224 the exercises (for more details on participation in each year, see Table 1). Most of the participating 
225 laboratories (81%) were located in Europe, while the rest (19%) was spread over different continents 
226 (North-America, Asia and Oceania) (Figure 2). The participants located within the European Union 
227 received the test samples, shipped on ice, during the following 24-48 hours while for the remaining 
228 participants from the other continents the average transport time was 2-4 days. Temperature during 
229 shipment was not recorded, but participants were asked to not analyse samples if defrosted upon 
230 reception (responsibility if the participant).
231
8232 2.5. Evaluation of results 
233 Participating laboratories were required to report measured concentrations of the target analytes in 
234 each sample type provided. Results of individual replicates were submitted. Furthermore, 
235 participants had to clearly highlight when concentrations were not quantifiable (i.e., below limits of 
236 quantification) or when the analysis for a certain compound was not performed. Limits of 
237 quantification for each participant were estimated with a fixed protocol and compared to self-
238 assessed limit of quantifications. It was established at a signal-to-noise ratio of 10 using the 
239 quantifier transition from chromatograms of samples spiked at the lowest validation level tested. The 
240 estimated limits of quantification were for all participating laboratories within the same order of 
241 magnitude and comparable to what was reported by each lab based on validation data. Since 2015, 
242 one spiking level was used to evaluate whether the analytical procedures of participants had limit of 
243 quantifications that are relevant in the context of WBE studies. If participants could not report values 
244 for this sample, they were notified that their analytical procedures did not reach relevant sensitivity.
245 First, the mean concentration (m) of replicates for each participant and for each sample type was 
246 calculated. Secondly, after testing for normality, a Grubbs’ test was performed to identify outliers 
247 which were excluded from further analysis. From the remaining means, the group’s mean [i.e., mean 
248 of means (M)] and the group’s standard deviation (SD) were computed. To evaluate the performance 
249 of each participant ( ), z-scores ( ) for every analyte and sample type were calculated as follows:𝑖 𝑧𝑖
250 𝑧𝑖 = 𝑚𝑖 ‒ 𝑀𝑆𝐷
251 Following the ISO standard, a laboratory passed the inter-laboratory exercise when its |z| ≤ 2 [21, 
252 25]. Participants with results that were identified as outliers (Grubb’s test) or had |z|-values > 2 were 
253 individually notified about the deviation and were allowed to recheck their submitted values for 
254 inconsistencies or errors. Note that no detail ( , M) was supplied with the notification of the 𝑧𝑖
255 deviation in order to maintain impartiality. If these laboratories were able to supply a viable 
256 explanation (such as transcription errors), they were allowed to resubmit corrected results. If 
257 accepted, newly submitted values were used to compute updated values for , M, SD and .𝑚𝑖 𝑧𝑖
258 The purpose of this iterative process lies in the goal of SCORE to advance and improve WBE. The 
259 inter-laboratory exercise was therefore used to assist laboratories in optimizing their analytical 
260 procedures and improve the overall performance.
261
262 3. Results and Discussion
263 3.1. Assigned value: group’s mean vs. nominal concentration 
264
9265 The z-score was calculated relative to the group’s mean (M). The main reasons for using M instead of 
266 the nominal concentration (i.e. spiking levels) as reference in the context of this inter-laboratory 
267 exercise are [21, 25]:
268 (i) Multiple scientific evaluations repeatedly revealed that spiking concentration levels did 
269 not necessarily display sufficient reliability to be used as an assigned value to calculate z-
270 scores;
271 (ii) For wastewater samples, the use of spiking levels as assigned value is out of the question 
272 because of the presence of unknown concentrations of the analytes (no nominal values 
273 exist); 
274 (iii) There is a sufficient number of laboratories that participated in the exercises along the 
275 years (Table 1);
276 (iv) Certified reference materials (CRMs) for analyzing illicit drugs in water samples are not 
277 available; 
278 (v) No recognised reference laboratories for this type of analysis exist;
279 (vi) The chosen approach was agreed by the participants as they were all informed on the 
280 calculation and evaluation procedures applied. 
281
282 Figure 3 shows the deviation of the group’s mean (M) from the nominal concentration (spiking level) 
283 for the methanol and tap water test samples. For the wastewater samples included in the exercises 
284 from 2012-2014, it is impossible to generate any meaningful plot because of the unknown 
285 background concentrations of the analytes present in this matrix. 
286 The results showed that the deviation of the group’s mean (M) from the nominal concentration was 
287 mostly < 25%, which was regarded by SCORE as an acceptable variability. The deviation for the 
288 matrix-free samples (i.e., methanol solvent) was mostly well below this 25% limit and suggested that 
289 in all laboratories, the reference standards (both native and isotope-labelled) used and the 
290 instrumental analysis (e.g. calibration and instrumental parameters) did not lead to substantial bias 
291 in the analysis of the target analytes, except for 6-MAM. However, in the presence of matrix, 
292 deviations of more than 25% occurred more often, in particular for 6-MAM and THC-COOH. 
293 Concentrations of 6-MAM were systematically underreported, for both the standard solution and tap 
294 water samples. In some occasions, the deviation amounted up to 60%. This systematic 
295 underestimation of 6-MAM could be due to: (i) inaccuracies during the preparation and spiking of the 
296 test samples (e.g. preparation and dilution of stock solution); (ii) stability issues of this analyte during 
297 preparation of the test samples and during storage and sample handling; (iii) issues with the 
298 analytical procedures applied by the laboratories. 
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299 The analysis of THC-COOH in the methanol samples gave acceptable results (deviation <25% and no 
300 systematic error), while deviations of up to 90% were observed in tap water samples in 2013 and 
301 2014. It is important to highlight that tap water samples were acidified in 2013 and, in the following 
302 year, sample acidification before filtration was still performed by multiple participants. These were 
303 later shown to have a negative impact on the measured concentrations of THC-COOH because of 
304 adsorption issues [23-24, 26]. Acidification may be the cause of the high variability observed for this 
305 analyte, but this is clearly not the whole picture. In fact, Causanilles et al. (2017) demonstrated that 
306 different (combinations of) parameters (pH, filtration, sorption) can have an influence on the analysis 
307 of THC-COOH in wastewater [26]. 
308 For COC, all samples across the different years showed deviations <25%, except for the three tap 
309 water samples in 2015. The nature of this systematic deviation (only one year) indicates the error 
310 likely occurred in the preparation of these test samples. 
311
312 3.2. Influence of different matrices and concentration levels on the group’s variability
313 The influence of the different matrix types on the performance of participating laboratories was 
314 assessed through analysis of the datasets from all years. Figures 4 and 5 illustrate the influence of the 
315 three matrices on the relative standard deviation (RSD) of the group. Overall, a lower RSD for the 
316 methanol samples compared to the waste- and tap water samples was observed (Wilcoxon rank sum 
317 test p-value <  = 0.05). This observation was not surprising considering that concentrations of the 
318 standard solution samples were in the µg/L range while in tap water and wastewater, samples 
319 concentrations were in the ng/L range. Furthermore, analysis of the methanol solution samples did 
320 not require any substantial sample preparation (i.e., direct injection with/without further dilution) 
321 compared to waste- and tap water samples, which required pre-concentration. A significant 
322 difference between the RSDs for tap water and wastewater samples was observed (Wilcox rank sum 
323 test p-value = 0.01,  = 0.05). For THC-COOH, high RSDs were observed for tap water and wastewater 
324 samples compared to the other analytes. Likewise, in the methanol solution, high RSDs were 
325 observed on several occasions (Figure 4). These findings further suggest that there are some issues 
326 with the analysis of this particular compound in water samples, as discussed earlier (Figure 3).
327 The difference in RSDs between tap and wastewater samples was further investigated using ANOVA 
328 (after log transforming the data to correct for deviation from normality and heteroscedasticity). 
329 Statistical analysis revealed that the spiking level showed the most significant influence on the 
330 group’s RSD (F(1,98) = 121.5, p < 0.0001), followed by the matrix type (F(1,98) = 10.9, p < 0.001) and 
331 the compound under analysis (F(6,98) = 3.0, p < 0.01). Because the matrix type was not the most 
332 influential parameter, the use of spiked tap water samples was deemed adequate for the purposes of 
333 the present inter-laboratory exercise. In fact, when using wastewater samples, (a) differences in 
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334 matrix effects occur between locations and (b) background concentrations of the analytes in 
335 wastewater are unknown and uncontrollable. As a result, it was not considered possible to use 
336 ‘representative’ wastewater for the purpose of this inter-laboratory exercise. Furthermore, by using 
337 tap water, labour and logistic costs linked to the preparation and distribution of additional samples 
338 to the participants could be reduced significantly. Issues related to the biodegradation and sorption 
339 of target analytes in wastewater during shipment could also be reduced. Furthermore, our study, 
340 including data over a six-year period, provides unique insights into how the molecular properties of 
341 the analytes, concentration levels and matrix type affect laboratory performance in the context of 
342 (waste)water analysis. The information and experience gained could hence be useful for other inter-
343 laboratory exercises confronted with similar matrices. 
344
345 3.3. Performance of laboratories
346 The evaluation of the results obtained by all laboratories discussed hereafter is based on the 
347 performances with the spiked tap water samples, as this matrix was shown to be appropriate (see 
348 section 3.2) and because of the issues with wastewater samples mentioned earlier (i.e., unknown 
349 background concentrations and potential stability issues). Figure 6 provides an overview of the 
350 proportion of satisfactory results per analyte type in the period of 2013-2016. A satisfactory result is 
351 regarded as a |z|-value ≤ 2 [21, 25]. Grubb’s outliers, non-detects (reported as below limit of 
352 quantification) and |z|-values > 2 are regarded as unsatisfactory. In the supporting information, 
353 detailed results for each laboratory over the different years are shown. The plots give an overview of 
354 the distribution of the z-scores of the group for the different years, matrices and spiking levels and 
355 detailed plots for results of the individual laboratories (including intra-laboratory variation).
356 In general, for BE, COC, MDMA, and AMP, the group’s performances were acceptable, with > 90% of 
357 satisfactory results. For METH and 6-MAM, the satisfactory result were around 80% in 2013. This can 
358 be linked to the fact that 3 out of 15 (METH) and 3 out of 10 (6-MAM) participants did not detect the 
359 analytes in the test samples. In 2014-2016, acceptable results for these two analytes were obtained, 
360 probably due to the higher concentration levels and improved performance of the analytical 
361 procedures of the participants. The unsatisfactory results obtained for THC-COOH analysis over years 
362 have drawn the attention of SCORE and triggered a further investigation of the effect that different 
363 pre-analytical steps (filtration and pH adjustment) have on the accuracy the analysis of this 
364 compound in wastewater [26]. 
365 It is important to mention that the aim of SCORE is to improve the reliability of WBE studies. 
366 Therefore, support was provided to laboratories that showed unsatisfactory results by means of 
367 short-term visits of a SCORE member and/or optimization of the analytical procedures (assistance 
368 with sample preparation and method validation). In most cases, this resulted in positive outcomes 
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369 for these laboratories in following exercises. This highlighted the need for follow-up of inter-
370 laboratory exercises combined with a continuous support to all participants. 
371
372 The z-scores regarding different concentrations of each analyte were visualised in scatter biplots (i.e., 
373 Youden plots, Figure 7) to assess the sources of variability among the participating laboratories. 
374 Inter-laboratory variation predominates if results were clustered in the upper right and lower left (= 
375 white) quadrants, while intra-laboratory variation predominates if results are clustered in the upper 
376 left and lower right (= grey) quadrants [25]. Furthermore, the distances of the plotted point relative 
377 to the 45-degree reference line and to the (0, 0) point (i.e. the Manhattan median) are both useful 
378 for the interpretation of inter-laboratory data. Points that lie close to the 45-degree reference line 
379 but far from the Manhattan median indicate a systematic error. Points that lie far from the reference 
380 line suggest large random errors. The majority of the participating laboratories was found within the 
381 white quadrants (Figure 7), meaning that inter-laboratory variability was predominant over the intra-
382 laboratory variability for all seven analytes. Only a few laboratories were occasionally outside of the 
383 |z|-values > 2 boundaries. For the latter, this implies large total errors, which were mainly 
384 systematic, as results were close to the 45-degree reference line but distant from the origin. 
385 Moreover, it should be noted that no recurrent erroneous results were observed, i.e., there were no 
386 laboratories with anomalous results for a certain analyte reported across different years. This 
387 supports the hypothesis that the observed errors were rather incidental and/or that these 
388 laboratories had improved their analytical procedures.  
389
390 3.4. Sources of variations and recommendations
391 The six-year data from inter-laboratory exercises for the analysis of illicit drug residues in water 
392 samples revealed variations linked to its setup and allowed to provide recommendations to improve 
393 future exercises. First, this study shows that the group’s mean should be used to evaluate 
394 performance of laboratories rather than the nominal (spiked) value. However, it is important that 
395 nominal values should always be considered to exclude pre-analytical issues, as demonstrated for 
396 THC-COOH. This observation triggered further investigations and recommendations to improve the 
397 WBE approach to estimate cannabis use [26]. Second, since concentration levels were found to be 
398 the main factor influencing performances (Figure 4, see section 3.2), spiking levels should be chosen 
399 carefully, and reflecting concentrations expected in real samples. Particularly, for the methanol 
400 standard samples, the use of different concentrations (e.g. Youden couple) instead of a single (high) 
401 level, as we did, will be useful to improve the assessment of laboratory performances. Third, it is 
402 important to prepare and transport test samples in the most optimal way in order to avoid stability 
403 and adsorption problems. The issues observed with 6-MAM and THC-COOH when samples were 
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404 acidified (see section 3.1) are a good example and highlight the need to consider other preservatives 
405 (e.g., sodium metabisulphite (Na₂S₂O₅) or sodium azide (NaN3)) to ensure analyte stability during 
406 transport and storage [27-28]. Furthermore, future inter-laboratory exercises should include an extra 
407 analysis of the test samples by the preparing laboratory directly after preparation of the test samples 
408 before freezing and shipment. This will improve understanding of the differences between the 
409 nominal spike and the assigned value.
410 Based on the experiences acquired from these six rounds of inter-laboratory exercises, 
411 recommendations related to analytical procedures used by individual laboratories for measuring 
412 illicit drugs and metabolites in wastewater can be formulated. Laboratories can freely choose their 
413 preferred sample preparation procedure and detection/quantification technique, but we strongly 
414 suggest that the methods comply with the following features. First, mass-labeled internal standards 
415 should be used for each analyte and spiked in samples before any filtration step. Second, pH 
416 adjustment - when needed - has to be conducted after internal standard spiking and/or filtration. 
417 This is particularly relevant for the analysis of THC-COOH in wastewater [26]. Third, freeze-thaw 
418 cycles of the samples should be minimized. Fourth, in-house quality control samples (e.g. spiked tap 
419 water or wastewater) should be prepared and analysed with each sample batch. Furthermore, 
420 centrifugation instead of filtration can be an alternative way to avoid the blockage and clogging of 
421 solid-phase extraction cartridges with particulates present in the wastewater. 
422
423 4. Conclusions
424 This study presents, for the first time, the results of an inter-laboratory testing scheme for the 
425 analysis of illicit drugs and metabolites in wastewater. By repeating this exercise for six years, we 
426 were able to improve the set-up of the testing scheme substantially, based on experiences gained 
427 over the years (e.g. matrix to be used, sample parameters, spiking levels) and to establish a reliable 
428 quality control system. The existence of such system is important to ensure high-quality data of WBE 
429 monitoring studies that can be used by stakeholders to obtain the most recent data on spatial and 
430 geographical trends in illicit drug use on a national and international scale.
431 The results of the exercise highlighted the importance of using the group’s mean rather than the 
432 nominal value as the assigned value, in particular due to the lack of certified reference materials for 
433 testing illicit drugs in wastewater. An investigation of the RSD associated with reported results 
434 showed that the most influential parameter was the spiking level, not the instrument (method) used 
435 or the type of matrix (i.e., tap or wastewater). Consequently, tap water was chosen for future 
436 exercises as it presents various advantages. Specifically, it allows to control spiking levels more easily, 
437 which is not possible with wastewater as unknown background concentrations exist. In fact, 
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438 substantial variations in composition and analyte concentrations occur, even within wastewater 
439 collected from a unique location. 
440 Regarding laboratories performances, the results from the inter-laboratory exercise show that these 
441 were generally satisfactory for COC, BE, MDMA, AMP and METH. An improvement was observed 
442 over the years and, in its latest round in 2016, more than 90% of the participating laboratories 
443 reported results |z|-value ≤ 2. In the case of 6-MAM and THC-COOH, results from the exercise 
444 showed that important pre-analytical issues still exist, and that sample pH has an important influence 
445 on the stability of the latter analytes. Whilst these issues still need to be solved, it is important to 
446 notice that none of the participating laboratories repeatedly (i.e., systematically) reported erroneous 
447 results for the same analyte across multiple years, emphasising the improvements in analytical 
448 performances which took place over the years. 
449 The results illustrate the effectiveness of the inter-laboratory testing scheme in assessing and 
450 improving laboratory performance in the framework of illicit drug analysis in wastewater. The 
451 exercise proved that measurements of individual laboratories were of high quality and that analytical 
452 follow-up is important in order to assist laboratories in improving the robustness and accuracy of 
453 WBE results. The set-up and procedures used in this exercise for the measurement of illicit drugs in 
454 wastewater and experiences gained during the six-year period are of importance for the 
455 development of other quality control systems dealing with the measurement of pharmaceuticals, 
456 personal care products and other contaminants in aqueous matrices. 
457 Wastewater-based epidemiology has gained importance, as numerous national and international 
458 organisations rely on its measurements to improve quantification of illicit drug use. Consequently, 
459 additional efforts will be needed in future to ensure the impeccable quality of reported results and 
460 tackle the existing and upcoming challenges. In particular, improving analytical performances for 
461 important compounds such as 6-MAM and THC-COOH and, at the same time, adapting protocols to 
462 integrate an ever growing number of relevant substances (e.g., new psychoactive substances) are 
463 among the main challenges that laboratories will face in future.  
464
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Figure 1. Inter-laboratory overview and scheme of the sample preparation and shipment for Module 
2.
21
Figure 2. Map with location of the participants of the inter-laboratory exercises
22
Figure 3. Deviation of the assigned value (= group’s mean) from the nominal value (= spiking level)  
for the standard solution (top) and the tap water samples (bottom) in relation to the assigned value 
for the seven analytes. The dotted line represents 25% deviation. Entries with deviations > 25% are 
marked with the year of the inter-laboratory exercise.
23
Figure 4. Relative standard deviation of the group in relation to the assigned value M (logarithmic 
scale) for the three matrices [standard solution (blue), tap water (green) and wastewater (red)] and 
seven analytes. All years (2011-2016) included.
24
Figure 5. Boxplot showing the difference in the group’s RSD for the three different matrices (MEOH = 
standard solution; TW = tap water; WW = wastewater) in 2013 and 2014 for all analytes. 
25
Figure 6. Percentage of participants with satisfactory results (|z| ≤ 2) for tap water samples spiked 
with seven analytes. The dotted line represents 90% satisfactory level.
26
479
480 Figure 7. Youden plots with z-scores of the low concentration value (x-axis) and the z-scores of the 
481 high concentration value (y-axis) for the seven analytes in tap water across the years. Each 
482 participant is presented by a unique number. The inner rectangle captures satisfactory z-scores.
